FIP1L1 and hypereosinophilic syndrome: Triptolide suppressed FIP1L1-PDGFRα expression, as well as downstream activation of STAT3, Erk and Akt to induce apoptosis of imatinib-resistant hypereosinophilic syndrome cells (166).